Nanomedicine in precision treatment of gastric cancer: current clinical landscape
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12068-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 02.06.2026. Verfasst von ShengJin Tu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Zigong Fourth People's Hospital, 1331 Ziwei Rd., Ziliujing Dist, Zigong, Sichuan, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Nanomedicine, Precision Medicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: Australian Academy of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Zigong Fourth People's Hospital, 1331 Ziwei Rd., Ziliujing Dist, Zigong, Sichuan, China.
- Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of General Surgery, Zigong Fourth People's Hospital, 1331 Ziwei Rd., Ziliujing Dist, Zigong, Sichuan, China. yanghua_dc@126.com.
Förderung
- Australian Academy of Science
Zitieren
APA
Tu, S., Wang, X. D., & Yang, H. (2026). Nanomedicine in precision treatment of gastric cancer: current clinical landscape. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12068-3
Vancouver
Tu S, Wang XD, Yang H. Nanomedicine in precision treatment of gastric cancer: current clinical landscape. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12068-3
BibTeX
@article{Tu2026,
author = {Tu, ShengJin and Wang, Xiao Dong and Yang, Hua},
title = {Nanomedicine in precision treatment of gastric cancer: current clinical landscape},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12068-3}
}
EUVIMED